Last update:

Immunology news

Medications

Newly discovered compounds help cells fight a wide range of viruses

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a defense pathway inside host cells. These compounds, they believe, could be used as antiviral drugs that ...

Oncology & Cancer

Researchers develop novel antibody-RNA therapy for resistant cancers

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models, according to a study reported ...

Diseases, Conditions, Syndromes

How lung repair mechanisms can help fight against tuberculosis

New research has found that delivering a stronger form of the tuberculosis vaccine directly to the lungs can help generate protective immune cells to help fight the disease. The research is published in the journal Mucosal ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Diseases, Conditions, Syndromes

Measles isn't just dangerous, it may erase your immune system

Blindness, pneumonia, severe diarrhea and even death—measles virus infections, especially in children, can have devastating consequences. Fortunately, we have a safe and effective defense. Measles vaccines are estimated ...

Immunology

Penicillin allergy testing needed to fight antibiotic resistance

Penicillins are first-choice antibiotics for many common infections, but more than one in 15 UK adults have a penicillin allergy label on their medical records. In the event of an infection, they will be prescribed alternative ...

Immunology

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

Immunology

New route into cells could make gene therapies safer

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular ...

Oncology & Cancer

Controlled physical barrier created to boost cancer immunotherapy

A study led by Prof. Liang Xingjie's team from the National Center for Nanoscience and Technology of the Chinese Academy of Sciences (CAS) reported a biomimetic physical barrier (BPB) that temporarily blocks T cell-tumor ...

Immunology

Immunotherapy resistance linked to cytoplasmic WEE1 protein

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells exploit these checkpoints to avoid immune detection. Immune checkpoint blockade (ICB)—a therapy ...

Oncology & Cancer

Plant compound slows cervical cancer growth in preclinical model

Cervical cancer is one of the most common gynecologic cancers worldwide and continues to be a leading cause of cancer-related death in women. While early detection through screening has improved outcomes, treatment options ...

Immunology

Study reveals why scleroderma affects more women than men

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma—a rare and often devastating autoimmune disease that causes ...

Diseases, Conditions, Syndromes

Antibody pair shows potential to defeat all SARS-CoV-2 variants

The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments developed during the pandemic are no longer effective. Now a team led by Stanford University researchers ...

Oncology & Cancer

Study finds new potential for prostate cancer immunotherapy

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment ...

Genetics

How p53 modulates the tumor immune microenvironment

Although there are tumor suppressor genes in normal cells to prevent cancer, gene mutations can cause a normal cell to become a cancerous one. Among those genes, TP53 (encoding the p53 protein) has been identified as the ...

Oncology & Cancer

How cancer hijacks the immune system by draining T cells' energy

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach.

Immunology

The rules of immunity: What decides T cell fate?

T cells are positioned at the frontline of the body's immune system to fight infection, cancer, and autoimmune disease. While different subtypes of T cells exist, how these cells take their different forms has remained elusive.

Immunology

How to treat spring allergies: A graduated approach

Spring brings warmer weather, but for allergy sufferers, it also means sneezing, wheezing and itchy eyes. Instead of enjoying the season, you may be battling congestion and brain fog. So, what can you do to manage your spring ...